Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
37.7M
-
Shares change
-
+872K
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
+$31.5M
-
Put/Call ratio
-
0.72
-
Number of buys
-
91
-
Number of sells
-
-66
-
Price
-
$36.18
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2018
201 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2018.
REPLIGEN CORP - COMMON STOCK (RGEN) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.7M shares
of 56.2M outstanding shares and own 67.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.37M shares), VANGUARD GROUP INC (2.96M shares), TimesSquare Capital Management, LLC (2.32M shares), OppenheimerFunds, Inc. (1.99M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.81M shares), Invesco Ltd. (1.64M shares), Conestoga Capital Advisors, LLC (1.6M shares), STATE STREET CORP (1.6M shares), DIMENSIONAL FUND ADVISORS LP (1.01M shares), and MACQUARIE GROUP LTD (987K shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.